Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Major Interest in Shares

2nd Feb 2011 12:38

RNS Number : 5569A
Alliance Pharma PLC
02 February 2011
 



For immediate release

2 February 2011

 

Alliance Pharma plc

 

TR-1: Notification of major interest in shares

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

Alliance Pharma

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

On market transfer between direct and indirect funds

3. Full name of person(s) subject to thenotification obligation:

Slater Investments Ltd

4. Full name of shareholder(s)  (if different from 3.):

5. Date of the transaction and date onwhich the threshold is crossed orreached:

1 February 2011

6. Date on which issuer notified:

2 February 2011

7. Threshold(s) that is/are crossed orreached:

Above 3%

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

GB0031030819

7,044,320

7,044,320

7,344,320

230,000

7,114,320

0.1%

3.03%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

7,344,320

3.13%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Catherine Mauger

15. Contact telephone number:

020 7220 9460

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLSSWFEEFFSEDE

Related Shares:

Alliance Pharma
FTSE 100 Latest
Value8,809.74
Change53.53